Drawing for VIDIERA

USPTO serial 78550987

VIDIERA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
DWYER, JOHN D
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with VIDIERA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Charles C. Wong

Charles C. Wong BECKMAN COULTER, INC.250 S. Kraemer Blvd.Brea, CA 92821UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Clinical and in vitro diagnostic chemicals and reagents for preparation, amplification, hybridization, separation, fractionation, detection and measurement of body fluids for nucleic acids and proteins, namely, diagnostic reagents for scientific and research use, and biochemicals, namely, monoclonal antibodies, polypeptides and precursors for in vitro scientific, research and genetic engineering useABANDONED—
005Chemicals and reagents for preparation, amplification, hybridization, separation, fractionation, detection and measurement of body fluids for nucleic acids and proteins, namely, diagnostic reagents for clinical or medical laboratory use, clinical medical reagents, diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology, and chemical reagents for medical useABANDONED—
009Automated laboratory equipment with software control and computational analysis for preparing body fluids with chemical reagents for nucleic acid and protein analysis, namely, automated sample preparation pipettors, automated amplification instruments that automate the Polymerase Chain Reaction (PCR) or similar target or signal amplification techniques, automated amplification and detection instruments that automate real-time PCR or similar target or signal amplification and detection techniques, and detection systems, namely, automated capillary electrophoresis, microarrays and other fluorescence detectorsABANDONED—
010Automated medical instruments and devices for preparing body fluids with chemical reagents for nucleic acid and protein analysis, namely, automated sample preparation pipettors, automated amplification instruments that automate the Polymerase Chain Reaction (PCR) or similar target or signal amplification techniques, automated amplification and detection instruments that automate real-time PCR or similar target or signal amplification and detection techniques, and detection systems, namely, automated capillary electrophoresis, microarrays and other fluorescence detectorsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ARAA): This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.

DateCodeEventWhat it means
Jun 3, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 3, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 27, 2007MAB4ABANDONMENT NOTICE MAILED - INTER PARTES DECISION—
Sep 27, 2007ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Sep 27, 2007OP.DOPPOSITION DISMISSED NO. 999999—
Jun 4, 2007ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 4, 2007REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 23, 2006OP.IOPPOSITION INSTITUTED NO. 999999—
Jun 22, 2006OPPFOPPOSITION PAPERS RECEIVED AT TTAB—
May 23, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 3, 2006NPUBNOTICE OF PUBLICATION—
Mar 31, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 24, 2006ALIEASSIGNED TO LIE—
Mar 21, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 21, 2006CNEAEXAMINERS AMENDMENT MAILED—
Mar 20, 2006XAECEXAMINER'S AMENDMENT ENTERED—
Mar 20, 2006CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 7, 2006ACECAMENDMENT FROM APPLICANT ENTERED—
Feb 17, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 17, 2006MAILPAPER RECEIVED—
Aug 22, 2005CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 20, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 19, 2005DOCKASSIGNED TO EXAMINER—
Jan 31, 2005NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance